Team-based Rapid Assessment of Community-level coronavirus Epidemics
TRACE-COVID-19 is a public health project that is gathering timely and lifesaving information that is essential for informing measures to slow the spread and minimize the impact of the disease. Because testing has been limited, and because only individuals with symptoms have been tested, no one knows how many people in Corvallis or Bend — or most other places — actually have the virus. TRACE-COVID-19 is filling that gap first in Corvallis and Bend, and we hope later in other Oregon communities and across the nation.
Participants in this project are helping save lives and enable a more effective response to COVID-19.
A number of households in a representative set of neighborhoods across Corvallis and Bend are being invited to participate in the study by field staff going door-to-door. Participants receive a home test kit to use inside their home and then return it to the staff.
By agreeing to participate in the TRACE-COVID-19 study, participants are helping public health leaders and scientists understand how prevalent the virus that causes COVID-19 is in Corvallis and Bend and how its prevalence is changing. Study results will help save lives. With a clearer understanding of how the virus spreads, public health leaders, health care providers and individuals can make informed decisions about policies and the use of time and resources to slow the spread of the virus and minimize its impacts.
It is critical that we all act quickly.
How it works
Samples obtained from home test kits are collected from community members in Corvallis and Bend. A team of scientists and public health experts at Oregon State University has developed the TRACE home test kit. The sampling kit includes a nasal swab, a plastic tube with a liquid to inactivate the virus and preserve the sample for analysis, a plastic bag and a disinfectant wipe to sanitize the bag. These simple, self-administered tests collect material from the entrance of the nose. They are more comfortable and less invasive than nasopharyngeal swabs seen in the media, which collect nasal secretions from the back of the nose and throat.
The kits are provided to a predetermined, representative set of households that agree to participate in the study. This sampling provides a snapshot of how prevalent the virus is in our community. The test screens for the virus in people who are infected and have symptoms, as well as those who are infected but do not show symptoms. The findings will help Oregon public health officials make informed decisions about where to concentrate health resources to combat the disease more effectively. The results also help participants make personal decisions about their own health and that of family members in their homes.